OakChart

Maravai LifeSciences Holdings Inc

MRVIHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 3:59 PM ET

7.70-0.16 (-2.04%)
2026-11-12 02:01 CET
Market cap
1,173.14 USD m
Revenue, TTM
213.00 USD m
Net income, TTM
-65.67 USD m
Free cash flow, TTM
-12.54 USD m
EPS diluted, TTM
-0.45
P/E
-
Compare

Price

MRVI against its 20, 50 and 200-day averages
2050200beat
4.006.008.007.6M15.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MRVIclose 7.7020-day 7.5550-day 7.39200-day 5.397.7052w high

18.3% under the 52-week high of 9.42 on 26 Aug 2026. 52-week low 2.80 on 31 Mar 2026. Last 15 sessions, 28.1% high to low

Volume 0.64× normal · the line is the 50-bar volume average

Profile

MRVI
52-week range, 74% of the way up
2.809.42

Maravai Lifesciences Holdings, Inc. engages in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm's brands include TriLink BioTechnologies, Cygnus, Glen Research, and Alphazyme. It operates through the TriLink and Cygnus segments. The TriLink segment manufactures and sells products used in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Cygnus segment sells biologic safety testing products and highly specialized analytical products for use in biologic manufacturing process development, including custom product-specific antibody and assay development services. It also operates through the following geographical segments: North America, Asia Pacific, Europe, the Middle East, and Africa, and Latin and Central America. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

IndexRUT
Employees435
IPONov 20, 2020
Beta0.63
ATR, 14d0.55
Rel volume0.64
Short float12.61%
Insider own25.31%
Inst own81.97%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.00B
Enterprise Value2.25B
Income-65.67M
Sales213.00M
Book/sh1.31
Cash/sh0.28
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees435
IPONov 20, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S9.40
P/B5.86
P/C27.23
P/FCF-
EV/EBITDA122.22
EV/Sales10.56
Quick Ratio3.35
Current Ratio4.66
Debt/Eq0.91
LT Debt/Eq0.89
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.45
EPS next Y-0.08
EPS next Q-0.04
EPS this Y75.51%
EPS next Y-6.11%
EPS next 5Y43.32%
EPS past 3/5Y- -
Sales past 3/5Y-40.53% -8.15%
EPS Y/Y TTM46.91%
Sales Y/Y TTM10.77%
EPS Q/Q47.45%
Sales Q/Q10.14%
EarningsNov 04 AMC
EPS/Sales Surpr.46.71% 5.26%

Ownership

Insider Own25.31%
Insider Trans-0.08%
Inst Own81.97%
Inst Trans6.65%
ROA-9.06%
ROE-29.76%
ROIC-17.71%
Gross Margin38.87%
Oper. Margin-17.16%
Profit Margin-30.83%
SMA201.95%
SMA504.24%
SMA20042.95%
Trades-

Technical

Shs Outstand149.20M
Shs Float111.47M
Short Float12.61%
Short Ratio4.40
Short Interest14.05M
52W High9.42 -18.26%
52W Low2.80 175.00%
Volatility8.51% 7.62%
ATR (14)0.55
RSI (14)51.68
Beta0.63
Rel Volume0.64
Avg Volume3.20M
Volume2,036,461

Performance

Perf Week-0.26%
Perf Month17.92%
Perf Quarter33.22%
Perf Half Y76.20%
Perf YTD136.92%
Perf Year136.92%
Perf 3Y50.10%
Perf 5Y-78.86%
Perf 10Y-
Recom1.89
Target Price9.50
Prev Close7.86
Price7.70
Change %-2.04%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 05, 2026InitiatedTTD CowenBuy$9+16.9%
Feb 26, 2025DowngradeRRobert W. BairdOutperform → Neutral$9 → $3-61.0%
Dec 19, 2024InitiatedGGuggenheimNeutral
Dec 05, 2024DowngradeGGoldmanNeutral → Sell$4.25-44.8%
Nov 14, 2024InitiatedWWolfe ResearchPeer Perform
Nov 08, 2024DowngradeWWilliam BlairOutperform → Mkt Perform
Aug 28, 2024InitiatedWWells FargoOverweight$10+29.9%
Aug 13, 2024DowngradeMMorgan StanleyOverweight → Equal-Weight$11 → $10+29.9%
Apr 10, 2024InitiatedCCraig HallumBuy$15+94.8%
Dec 12, 2023UpgradeBBofA SecuritiesNeutral → Buy$10 → $8+3.9%

Peers

Mkt cap
TickerCompanyMkt cap
TECHBio-Techne Corp11.44B
TWSTTwist Bioscience Corp8.07B
CDXSCodexis Inc106.93M
RGENRepligen Corp11.03B
AVTRAvantor Inc10.66B
DHRDanaher Corp165.55B
TMOThermo Fisher Scientific Inc265.92B
AZTAAzenta Inc2.14B
CRLCharles River Laboratories International Inc16.42B
LABStandard BioTools Inc253.85M

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ORESHACK KURTGeneral CounselJun 10 '26Sale5.1025,000127,500335,767Jun 10 05:06 PM
ORESHACK KURTGeneral CounselJun 09 '26Sale5.0625,000126,500360,767Jun 10 05:06 PM
ORESHACK KURTOfficerJun 10 '26Proposed Sale5.1025,000127,500Jun 10 12:00 PM
ORESHACK KURTOfficerJun 09 '26Proposed Sale5.0625,000126,500Jun 09 10:31 AM
PRAHALAD MURALIFormer DirectorDec 23 '25Proposed Sale3.333,95113,138Dec 23 03:00 PM
Hopfield JessicaFormer DirectorDec 19 '25Proposed Sale3.4853,951187,526Dec 19 04:38 PM
LUCIER GREGORY TDirectorDec 05 '25Buy3.7051,472190,446106,595Dec 09 04:36 PM
LUCIER GREGORY TDirectorDec 08 '25Buy3.6748,528178,098155,123Dec 09 04:36 PM
Brust BerndChief Executive OfficerNov 13 '25Buy3.25216,212702,689466,771Nov 17 04:48 PM
Brust BerndChief Executive OfficerNov 12 '25Buy3.2193,358299,679250,559Nov 13 05:27 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
IBBiShares Biotechnology ETFAUM: 11.36B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
KOMPState Street SPDR S&P Kensho New Economies Composite ETFAUM: 2.46B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-04-0.030-0.056-0.09045.8543.569
2026Q22026-08-06-0.020-0.044-0.08451.4448.678
2026Q12026-05-070.010-0.048-0.02665.8453.008
2025Q42026-02-25-0.040-0.070-0.24649.8749.0511
2025Q32025-11-06-0.080-0.082-0.17741.6349.0211
2025Q22025-08-11-0.080-0.074-0.27547.4047.3712
2025Q12025-05-12-0.080-0.071-0.20946.8544.2515
2024Q42025-03-18-0.060-0.040-0.18456.5657.3815
2024Q32024-11-07-0.020-0.008-0.70065.2067.5513
2024Q22024-08-070.0000.001-0.05673.4071.9212
2024Q12024-05-08-0.020-0.026-0.09164.1860.5411
2023Q42024-02-220.010-0.012-0.80274.1464.3711
2023Q32023-11-07-0.0100.006-0.04966.8775.4711
2023Q22023-08-070.0000.013-0.05068.9171.1012
2023Q12023-05-080.0300.032-0.00179.0380.0012
2022Q42023-02-220.3500.3410.280204.71204.9312

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.5950.3550.705284.11275.25
2021FY1.6001.5171.561799.24779.14
2022FY1.8001.7931.670883883.43
2023FY0.0300.002-0.902288.95279.27
2024FY-0.100-0.078-1.050259.19260.15
2025FY-0.290-0.312-0.900185.74184.93
2026FY--0.071--214.35
2027FY--0.075--224.41
2028FY--0.053--238.36
2029FY--0.025--249.63
2030FY--0.040--273.8

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0692151.1849.4052.10
2026Q4S2026-11-0591151.1349.4052.10
2026Q4S2026-11-0490050.9249.3052.51
2026Q4S2026-10-2190050.9249.3052.51
2026Q4S2026-10-0290550.9249.3052.51
2026Q4S2026-09-2880551.1149.3052.51
2026Q4S2026-09-0890650.6747.2052.51
2026Q4S2026-09-0780650.6647.2052.51
2026Q4S2026-08-0780650.6647.2052.51
2026Q4S2026-07-2280051.7049.8053.90
2026Q4S2026-07-1081451.7049.8053.90
2026Q4S2026-06-0381451.7049.8053.90
2026Q4S2026-05-2981451.7049.8053.90
2026Q4S2026-05-1291451.6449.8053.90

Estimate history

EPS, annual-0.183-0.0880.7051.5611.67-0.902-1.05-0.906-0.4482
Period20182019202020212022202320242025TTM
EPS, quarterly-0.7-0.184-0.209-0.275-0.177-0.246-0.026-0.084-0.093
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual123.833143.14284.098799.24883.001288.945259.185185.743213
Period20182019202020212022202320242025TTM
Sales, quarterly65.256.40646.8547.39741.6349.86665.83751.44245.851
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual96.64796.64796.647131.488131.692132.228141.976145.324149.204
Period20182019202020212022202320242025MRQ
Shares, quarterly141.589141.976143.958144.615144.718145.324147.496148.888149.204
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue213.00185.74259.19288.94883.00799.24284.10143.14123.83
Cost of Goods Sold Incl. D&A130.21154.25153.48151.34171.76146.4687.2574.8568.77
Gross Profit82.7831.49105.71137.60711.24652.78196.8568.2955.07
Selling, General and Administrative Excl. Other119.34127.48168.79141.80125.55107.8395.9543.9837.69
Research and Development14.7717.4019.2217.2818.3715.229.303.634.50
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-36.56-95.99-63.08-4.20585.69544.95100.9024.3117.38
Interest Expense21.1426.9947.7045.8920.4130.2630.7429.9627.40
Unusual Expense63.27120.50175.76-641.4315.79-4.557.590.326.56
Net Income Before Taxes-115.41-234.97-261.48617.74551.47530.7681.70-5.85-16.50
Income Taxes-0.39-4.21-1.86756.1160.8161.522.88-0.650.42
Consolidated Net Income-115.02-230.76-259.62-138.38490.66469.2578.82-5.20-16.91
Net Income From Continuing Operations-65.67-130.77-144.85-119.03220.21182.0476.89-8.48-17.73
Net Income-65.67-130.77-144.85-119.03220.21182.0476.89-8.48-17.73
EPS (Recurring)-0.14-0.32-0.16-4.311.711.550.76-0.09-0.14
EPS (Basic, Before Extraordinaries)-0.45-0.91-1.05-0.901.671.590.80-0.09-0.18
EPS (Diluted)-0.45-0.91-1.05-0.901.671.560.70-0.09-0.18
EBITDA18.41-35.51-6.2144.58623.80569.70126.7448.3939.72
Non-Operating Income (Expense)5.558.5025.0626.391.9811.5319.130.120.09
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense24.4823.8439.0427.3214.757.6317.981.231.68
Price To Earnings Ratio---36.217.9827.1439.0855.82-
Price To Sales Ratio5.362.532.902.994.1413.529.54--
Gross Margin38.8716.9540.7947.6280.5581.6769.2947.7144.47
Operating Margin-17.16-51.68-24.34-1.4566.3368.1835.5216.9814.03
Net Margin-30.83-70.41-55.89-41.1924.9422.7827.06-5.92-14.32
Shares Outstanding149.20145.32141.98132.23131.69131.4996.6596.6596.65
Market Capitalization1,173.141,173.14773.05865.841,882.344,049.492,710.932,703.20-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue45.8551.4465.8449.8741.6347.4046.8556.41
Cost of Goods Sold Incl. D&A29.6630.7932.1437.6236.5840.2339.7338.04
Gross Profit16.1920.6533.7012.245.057.177.1218.36
Selling, General and Administrative Excl. Other33.5835.5531.2318.9813.8635.6340.8245.06
Research and Development3.393.703.893.793.844.884.894.56
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-17.39-14.902.47-6.74-8.81-28.47-33.70-26.69
Interest Expense4.034.815.756.556.846.826.7811.26
Unusual Expense3.233.204.6352.2132.2338.8615.4614.62
Net Income Before Taxes-24.07-21.80-6.53-63.01-45.15-74.12-52.69-46.50
Income Taxes-0.07-0.17-0.150.01-0.09-4.290.16-0.01
Consolidated Net Income-24.00-21.63-6.38-63.02-45.06-69.84-52.85-46.49
Net Income From Continuing Operations-13.84-12.42-3.73-35.68-25.56-39.59-29.95-26.14
Net Income-13.84-12.42-3.73-35.68-25.56-39.59-29.95-26.14
EPS (Recurring)-0.08-0.07-0.000.01-0.02-0.09-0.13-0.11
EPS (Basic, Before Extraordinaries)-0.09-0.08-0.03-0.25-0.18-0.27-0.21-0.18
EPS (Diluted)-0.09-0.08-0.03-0.25-0.18-0.27-0.21-0.18
EBITDA-3.54-1.5015.458.006.64-13.08-18.79-12.17
Non-Operating Income (Expense)0.571.111.382.502.730.023.256.08
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.998.065.333.107.155.368.228.33
Price To Sales Ratio5.364.422.022.542.161.611.312.98
Gross Margin35.3140.1451.1924.5512.1415.1215.2132.55
Operating Margin-37.92-28.973.76-13.51-21.15-60.06-71.93-47.32
Net Margin-30.18-24.14-5.67-71.55-61.39-83.53-63.92-46.35
Shares Outstanding149.20148.89147.50145.32144.72144.62143.96141.98
Market Capitalization1,149.26920.44414.26471.32415.23346.98317.47773.05

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments216.89322.40574.96632.14551.27236.1824.7021.87
Short Term Receivables25.5039.2255.72146.81117.5151.2218.8315.99
Inventories40.4950.0851.4043.1551.5633.3014.2014.31
Other Current Assets13.3717.4517.8325.8019.7010.892.821.64
Total Current Assets296.25429.15699.91847.90740.04331.6060.5553.80
Net Property, Plant & Equipment190.74217.03222.65116.5946.33101.3194.3142.58
Total Investments and Advances0.000.008.5611.360.000.000.000.00
Intangible Assets280.97354.83547.02500.33270.34401.93422.13442.40
Deferred Tax Assets--0.00765.80808.12431.70--
Other Assets2.627.249.3240.3353.454.160.810.89
Total Assets770.581,008.241,487.452,282.321,918.281,270.69577.80539.68
Short Term Debt Incl. Current Port. of LT Debt14.2013.7112.8511.719.726.002.502.50
Accounts Payable2.9111.9610.735.998.158.177.483.60
Other Current Liabilities27.8131.3063.8992.4475.90116.6119.5829.82
Total Current Liabilities44.9256.9787.47110.1493.78130.7829.5635.92
Long Term Debt350.51362.98598.11522.00524.59584.78387.70337.39
Provision for Risks Charges0.000.000.000.000.000.000.001.68
Deferred Tax Liabilities2.25-6.39--8.6114.7015.86
Other Liabilities0.2011.095.60744.93754.55391.781.210.82
Total Liabilities397.87431.04697.571,377.071,372.911,115.94433.17391.66
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity212.38325.29416.75545.22315.5088.51141.40144.41
Total Shareholders Equity212.38325.29416.75545.22315.5088.51141.40144.41
Accumulated Minority Interest160.33251.92373.13360.02229.8666.233.233.61
Total Equity372.71577.21789.88905.24545.36154.75144.63148.02
Total Liabilities & Stockholders Equity770.581,008.241,487.452,282.321,918.281,270.69577.80539.68
Book Value Per Share1.462.293.154.142.400.921.461.49
Tangible Book Value Per Share-0.47-0.21-0.990.340.34-3.24-2.90-3.08
Full-Time Employees435570650610470410--
Price to Book Ratio5.992.241.663.7417.4630.6319.12-
Return on Assets-14.70-11.61-6.3110.4811.428.32-1.52-
Return on Equity-48.64-39.04-24.7551.1790.1266.89-5.93-
Return on Invested Capital-23.23-21.04-11.7320.6321.6711.42-1.60-3.68
Quick Ratio5.696.657.417.317.342.281.571.10
Current Ratio6.607.538.007.707.892.542.051.50

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-115.02-230.76-259.62-138.38490.66469.2578.82-5.20-16.91
Depreciation54.9760.4756.8748.7838.1024.7525.8425.8223.84
Other Funds (Non Cash)78.20120.72221.58-636.979.974.2917.112.378.41
Funds from Operations18.13-49.5918.8428.38581.06545.20116.2921.8215.65
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-23.23-7.98-12.6197.84-45.08-176.6335.892.29-15.84
Cash from Operating Activities-5.10-57.576.22126.22535.98368.57152.1924.11-0.19
Capital Expenditures-7.44-13.15-31.16-65.55-17.09-14.85-25.41-17.15-3.61
Net Assets From Acquisitions0.00-18.990.00-69.62-238.970.00-123.030.000.00
Sale of Fixed Assets and Businesses0.000.737.140.000.62120.5034.500.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.00-0.300.00-13.280.000.000.000.00
Other Sources0.000.000.0012.871.100.000.000.000.16
Cash from Investing Activities-7.44-31.41-24.32-122.31-267.61105.66-113.94-17.15-3.45
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.00-0.022.361.71292.13-0.23-0.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00-42.80-0.23-0.01
Sale of Common Pref Stock0.000.000.00-0.022.361.71334.930.000.00
Proceedsfrom Stock Options0.000.000.00-0.020.000.00334.610.000.00
Issuance or Reduction of Debt, Net-148.60-5.44-234.07-5.77-5.44-6.00187.63-2.6455.43
Change in Long Term Debt-148.60-5.44-234.07-5.77-5.44-6.00187.63-2.6455.43
Issuance of Long Term Debt146.430.000.950.008.460.00599.710.00310.63
Reduction of Long Term Debt-295.03-5.44-235.03-5.77-13.89-6.00-412.08-2.64-255.20
Net Financing Active Other Cash Flow-8.99-11.06-0.40-55.30-184.42-154.76-306.54-1.30-64.59
Other Financing Activities Uses-9.00-12.44-9.69-61.47-184.42-154.76-306.54-1.30-64.59
Cash from Financing Activities-157.59-16.50-234.47-61.09-187.50-159.05173.22-4.17-9.17
Exchange Rate Effect0.07-0.03-0.000.00-0.090.020.03-0.07
Net Change in Cash-170.06-105.51-252.56-57.1880.87315.09211.482.83-12.87
Free Cash Flow-12.54-70.72-23.4360.67518.89353.72126.786.97-3.73
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow---14.247.0430.5421.38--
Deferred Taxes & Investment Tax Credit--0.020.01754.9442.3246.90-5.46-1.160.32

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments73.5170.58165.92216.89243.57269.91
Short Term Receivables25.7131.1433.4125.5022.5427.88
Inventories43.2541.2340.4640.4945.3346.67
Other Current Assets11.5312.7111.9413.3714.4315.30
Total Current Assets154.00155.66251.74296.25325.87359.76
Net Property, Plant & Equipment183.93142.41146.93190.74158.62162.73
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets260.39267.80274.32280.97315.31322.50
Other Assets1.7437.8740.232.6249.4051.98
Total Assets600.07603.75713.22770.58849.19896.97
Short Term Debt Incl. Current Port. of LT Debt2.881.125.4414.2014.5014.24
Accounts Payable6.487.128.542.918.0011.53
Other Current Liabilities23.7030.1728.6527.8139.0843.91
Total Current Liabilities33.0638.4242.6244.9261.5769.68
Long Term Debt174.98175.57265.44350.51353.44356.84
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---2.251.852.03
Other Liabilities51.8634.1736.070.200.470.44
Total Liabilities259.90248.16344.13397.87417.33428.98
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity195.89204.62211.56212.38245.44265.86
Total Shareholders Equity195.89204.62211.56212.38245.44265.86
Accumulated Minority Interest144.28150.97157.52160.33186.42202.12
Total Equity340.17355.59369.08372.71431.86467.98
Total Liabilities & Stockholders Equity600.07603.75713.22770.58849.19896.97
Book Value Per Share1.311.371.431.461.701.84
Tangible Book Value Per Share-0.43-0.42-0.43-0.47-0.48-0.39
Full-Time Employees---435--
Price to Book Ratio5.864.351.941.921.561.15
Return on Assets-9.06-10.31-12.50-14.70-11.40-16.61
Return on Equity-29.76-32.90-40.83-48.64-41.06-55.41
Return on Invested Capital-3.73-3.27-0.78-6.34-4.27-6.36
Quick Ratio3.352.984.965.694.564.49
Current Ratio4.664.055.916.605.295.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-24.00-21.63-6.38-63.02-45.06-69.84
Depreciation13.8513.4112.9814.7315.4415.39
Other Funds (Non Cash)12.2113.147.8944.969.6543.04
Funds from Operations2.064.9214.49-3.34-19.96-11.41
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.96-0.93-5.83-19.434.821.14
Cash from Operating Activities5.013.998.66-22.77-15.15-10.27
Capital Expenditures-0.52-0.37-4.44-2.11-2.93-2.87
Net Assets From Acquisitions0.000.000.000.000.00-0.36
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.52-0.37-4.44-2.11-2.93-3.24
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-96.45-51.36-0.79-1.56-1.55
Change in Long Term Debt0.00-96.45-51.36-0.79-1.56-1.55
Issuance of Long Term Debt0.00146.430.000.000.000.00
Reduction of Long Term Debt0.00-242.88-51.36-0.79-1.56-1.55
Net Financing Active Other Cash Flow-1.57-2.52-3.87-1.03-6.690.01
Other Financing Activities Uses-1.57-2.52-3.87-1.04-6.690.01
Cash from Financing Activities-1.57-98.98-55.23-1.82-8.25-1.53
Exchange Rate Effect0.010.020.030.01-0.01-
Net Change in Cash2.93-95.34-50.97-26.68-26.33-15.15
Free Cash Flow4.493.624.23-24.88-18.08-13.14

Revenue breakdown

Asia Pacific2024: 89.38M 2025: 41.47M
EMEA2024: 42.06M 2025: 30.92M
Latin And Central America2024: 662.00K 2025: 971.00K
North America2024: 127.09M 2025: 112.38M
Cygnus2024: 62.84M 2025: 65.96M
TriLink2024: 196.35M 2025: 119.79M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.63%14.1M111.3M3.15M
2026-10-1512.00%13.3M111.3M3.22M
2026-09-3012.43%13.8M111.2M3.24M
2026-09-1511.12%12.4M111.2M3.48M
2026-08-319.86%11.0M111.2M3.52M
2026-08-148.47%9.4M110.8M2.81M
2026-07-318.00%8.5M106.4M3.03M
2026-07-158.72%9.3M106.4M2.94M
2026-06-308.29%8.8M106.3M2.73M
2026-06-158.14%8.7M106.3M2.44M
2026-05-297.49%7.9M105.1M2.20M
2026-05-158.08%8.5M105.4M1.99M
2026-04-308.49%8.9M104.6M1.63M
2026-04-158.83%9.2M104.6M1.50M
2026-03-319.13%9.5M104.2M1.38M
2026-03-139.33%9.7M104.2M1.21M
2026-02-2710.21%10.6M104.2M1.18M
2026-02-1310.61%11.0M103.2M1.24M
2026-01-3010.67%11.3M105.8M1.32M
2026-01-1511.61%12.3M105.8M1.36M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.707.100.0018.8040.000.000.942-0.0560.001
call5.001.304.602.198.4580.000.000.864-0.0490.003
call7.500.002.051.054.1981,7560.000.601-0.0620.005
call10.000.000.700.101.5492340.000.169-0.0270.003
call12.500.001.900.152.3356.000.000.125-0.0330.002
put2.500.001.900.007.0760.000.00-0.058-0.0550.001
put5.000.001.900.103.30936.000.00-0.136-0.0490.003
put7.500.100.501.021.27016.000.00-0.399-0.0610.005
put10.000.503.900.004.8690.000.00-0.831-0.0250.003
put12.502.856.400.005.8900.000.00-0.875-0.0310.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-29SCHEDULE 13GSEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-29SCHEDULE 13GSEC
2026-06-23SCHEDULE 13GSEC
2026-06-10144Filing for proposed sale of securities under Rule 144.SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-09144Filing for proposed sale of securities under Rule 144.SEC
2026-06-038-KCurrent report2026-06-02SEC
2026-05-298-KCurrent report2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-284/A2026-05-26SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600254.00K2
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-12368.54K200
2025-111.51M300

Institutional holders

Manager% owned
GTCR LLC13.66%
BlackRock, Inc.6.76%
BRAIDWELL LP5.90%
12 West Capital Management LP4.79%
FMR LLC4.63%
MILLENNIUM MANAGEMENT LLC4.41%
VANGUARD CAPITAL MANAGEMENT LLC3.58%
Ophir Asset Management Pty Ltd3.27%
RENAISSANCE TECHNOLOGIES LLC3.12%
Nuveen, LLC2.34%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.51%
First Eagle Small Cap Opportunity Fund2.20%
iShares Russell 2000 ETF2.01%
Nuveen Quant Small Cap Equity Fund1.08%
Columbia Small Cap Growth Fund1.04%
VANGUARD EXTENDED MARKET INDEX FUND0.99%
Meridian Contrarian Fund0.86%
Fidelity Small Cap Growth Fund0.86%
Fidelity Small Cap Index Fund0.84%
ROYCE MICRO-CAP TRUST, INC.0.77%

OakChart. MRVI. Cached 15 minutes.